Navigation Links
Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
Date:3/20/2013

KANSAS CITY, Kan. and BOSTON, March 20, 2013 /PRNewswire/ -- Aratana Therapeutics, Inc., a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription medications for cats and dogs (companion animals), announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.  The number of shares to be offered and the price range for the proposed offering have not yet been determined.

Stifel and Lazard Capital Markets will act as book-running managers for the offering.  William Blair, JMP Securities, and Craig-Hallum Capital Group will act as co-managers.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective.  These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus.  Copies of the preliminary prospectus related to the offering may be obtained, when available, from Stifel, Nicolaus & Company, Incorporated, One Montgomery Street , Suite 3700, San Francisco, California 94104, or by calling (415) 364-2720; or from Lazard Capital Markets LLC, Attn: Syndicate Department, 30 Rockefeller Plaza, 48th Floor, New York, NY 10020, or by calling (800) 542-0970.

 


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
2. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
3. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
4. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
5. Aratana to Participate in Leerink Swanns November Management Access Days
6. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
7. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
8. Autoinjectors to 2018 - Devices, Therapeutics, Markets, Strategies and Prospects
9. ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
10. Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
11. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... LONDON , March 23, 2017 ... for its CTX cells in chronic stroke patients, despite not ... its primary outcome measure, the Action Research Arm Test (ARAT). ... progress to a pivotal controlled clinical study in 2017. Beyond ... pigmentosa (RP) trial in 2017 and Phase I data from ...
(Date:3/23/2017)... -- During the "Nudging for Good" ... , My UV Patch, La Roche-Posay,s digital breakthrough ... ones, was awarded the Diamond Award by the ... "Nudging for Good" Award aims to honor brands ... to change behaviour and adopt a healthier and/or ...
(Date:3/23/2017)... The Board of Directors of NeuroVive Pharmaceutical ... which is to take place on Thursday, April 27, 2017, at ... Sweden . ... Please see the attached notification, which is being announced within short ... Pharmaceutical AB (Publ) The Board Of Directors About NeuroViveNeuroVive ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... ... MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 — ... the new EU MDR language change the way manufacturers approach CERs? , ...
(Date:3/23/2017)... Marina del Rey, CA (PRWEB) , ... March ... ... version of its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st ... iCode Assurance optimizes and accelerates the coding audit process for all medical chart ...
(Date:3/23/2017)... ... March 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy ... of published author Bonetta Rose, a wife, mother and grandmother committed to sharing her ... Faith Publishing, Bonetta Rose‘s new book presents actual events in the life of her ...
(Date:3/23/2017)... ... March 23, 2017 , ... “My Journey Through Heaven”: the true-life account of ... profound faith of God’s promise of Heaven for His people. “My Journey Through Heaven” ... with his wife, three children and six grandchildren living and doing for God as ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To Atheist ... To Atheist Manifesto” is the creation of published author Richard Hostetter, a former ... years. He holds graduate degrees from Kent State University and the University of ...
Breaking Medicine News(10 mins):